Picture of Arbutus Biopharma logo

ABUS Arbutus Biopharma Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Arbutus Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments90.8123155147126
Net Total Accounts Receivable
Net Total Receivables1.21.310.8991.351.78
Prepaid Expenses
Total Current Assets93.8128161151132
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment11.49.338.076.816.09
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets106137204195144
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities7.839.5411.232.922.5
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities32.835.13558.638.4
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity72.7102169137106
Total Liabilities & Shareholders' Equity106137204195144
Total Common Shares Outstanding
Total Preferred Shares Outstanding